CPVT | Jotup

Solid Biosciences Provides Fourth Quarter and Full-Year 2023 Business Update and Financial Results

Retrieved on:

Wednesday, March 13, 2024

Research, AAV, CFO, CPVT, Patient, Fast Track, Collaboration, Sale, Acquisition, Hope, Investment, Solid, Safety, CMO, FDA, Pharmaceutical industry

CHARLESTOWN, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided a business update.

Key Points:

"2023 was an exciting and transformational year for Solid where we completed the integration with AavantiBio, while diversifying and expanding our pipeline.
Research and development expenses for the fourth quarter of 2023 were $15.4 million, compared to $21.3 million for the fourth quarter of 2022.
General and administrative expenses for the fourth quarter of 2023 were $6.8 million, compared to $7.6 million for the fourth quarter of 2022.
Net loss for the fourth quarter of 2023 was $20.3 million, compared to $15.2 million for the fourth quarter of 2022.

Daily Power Generation Gain Per Watt 4.76% Higher! Risen Energy Release Latest Empirical Data on Hyper-ion HJT Modules

Retrieved on:

Thursday, March 14, 2024

Electricity, CPVT, Research, MBB, Carbon, HJT, PERC, Multimedia, LCOE, Silicon, Renewable energy

In both 2020 and 2021, its HJT modules claimed the top spot globally in terms of shipments.

Key Points:

In both 2020 and 2021, its HJT modules claimed the top spot globally in terms of shipments.
Then, in 2022, significant upgrades and iterations were made to its HJT products, leading to the introduction of the Hyper-ion HJT products.
This marked the first time that the mass production power of modules surpassed 700W, setting numerous new world records for module power in the process.
), the company's Hainan base has once again released the latest half-year empirical data, making the economic comparison of HJT modules even more evident.

Daily Power Generation Gain Per Watt 4.76% Higher! Risen Energy Release Latest Empirical Data on Hyper-ion HJT Modules

Retrieved on:

Thursday, March 14, 2024

Electricity, CPVT, Research, MBB, Carbon, HJT, PERC, LCOE, Silicon, Renewable energy

In both 2020 and 2021, its HJT modules claimed the top spot globally in terms of shipments.

Key Points:

In both 2020 and 2021, its HJT modules claimed the top spot globally in terms of shipments.
Then, in 2022, significant upgrades and iterations were made to its HJT products, leading to the introduction of the Hyper-ion HJT products.
This marked the first time that the mass production power of modules surpassed 700W, setting numerous new world records for module power in the process.
), the company's Hainan base has once again released the latest half-year empirical data, making the economic comparison of HJT modules even more evident.

Power Generation Gain Reached 6.86%, Empirical Data of Risen Energy's HJT Hyper-ion Module in Yinchuan and Hainan Released by CPVT

Retrieved on:

Thursday, February 8, 2024

Carbon, Electricity, Temperature, Topcon, BSF, Multimedia, PV, CPVT, LCOE, PERC, HJT, Renewable energy

Figure 1 compares the power generation data of the HJT Hyper-ion modules and the PERC modules at the empirical study base in Yinchuan in 2023Q4.

Key Points:

Figure 1 compares the power generation data of the HJT Hyper-ion modules and the PERC modules at the empirical study base in Yinchuan in 2023Q4.
Risen Energy collected the power generation data of HJT Hyper-ion modules and the PERC modules at Hainan base in 2023Q4.
The empirical performance of the HJT Hyper-ion modules at CPVT Hainan base aligns closely with our simulation results, indicating a 5.51% higher power generation compared to PERC modules.
Risen Energy's empirical projects are currently well under way, and the company will continue to disclose the empirical data as it is updated and released.

Power Generation Gain Reached 6.86%, Empirical Data of Risen Energy's HJT Hyper-ion Module in Yinchuan and Hainan Released by CPVT

Retrieved on:

Thursday, February 8, 2024

Carbon, Electricity, Temperature, Topcon, BSF, PV, CPVT, LCOE, PERC, HJT, Renewable energy

Figure 1 compares the power generation data of the HJT Hyper-ion modules and the PERC modules at the empirical study base in Yinchuan in 2023Q4.

Key Points:

Figure 1 compares the power generation data of the HJT Hyper-ion modules and the PERC modules at the empirical study base in Yinchuan in 2023Q4.
Risen Energy collected the power generation data of HJT Hyper-ion modules and the PERC modules at Hainan base in 2023Q4.
The empirical performance of the HJT Hyper-ion modules at CPVT Hainan base aligns closely with our simulation results, indicating a 5.51% higher power generation compared to PERC modules.
Risen Energy's empirical projects are currently well under way, and the company will continue to disclose the empirical data as it is updated and released.

Risen Energy Shines as The Only Winner in the Module Category at PV magazine Awards 2023

Retrieved on:

Thursday, January 11, 2024

CPVT, Watt, Supervision, PV, Temperature, Electricity, 435th, Carbon, Risen, Topcon, HJT, PERC, Modularity, Renewable energy

As the sole recipient in the module category, Risen Energy's triumph stands as a compelling testament to their unwavering dedication to excellence.

Key Points:

As the sole recipient in the module category, Risen Energy's triumph stands as a compelling testament to their unwavering dedication to excellence.
The PV Magazine Awards 2023 recognized cutting-edge advancements and honored top-tier innovations in the solar industry.
"700 W-plus power output is a notable achievement in any solar module, but the 2023 Modules winner packs a heap of innovation inside to set it apart."
"It is a no-brainer for me in a module category the highest efficiency module deserves some credit."

Power Generation 5.13% Higher -- Risen Energy Released Empirical Data of HJT Hyper-ion Modules

Retrieved on:

Monday, November 13, 2023

Carbon, Supervision, Topcon, LCOE, CPVT, PERC, Multimedia, Organization, HJT, Carbon footprint, Philosophy, Renewable energy, Mobile phone

Risen Energy compared the power generation of HJT Hyper-ion modules relative to PERC modules and TOPCon modules through simulations in over 20 countries and regions around the world with typical climatic environments, as shown in Figure 1.

Key Points:

Risen Energy compared the power generation of HJT Hyper-ion modules relative to PERC modules and TOPCon modules through simulations in over 20 countries and regions around the world with typical climatic environments, as shown in Figure 1.
The simulation results indicate that HJT modules consistently exhibit a significant increase in power generation compared to TOPCon and PERC modules across various regions.
In addition to the simulation, to further explore the real-world power generation performance of HJT Hyper-ion products, Risen Energy collaborated with various organizations and clients to conduct empirical power generation tests in some regions worldwide.
Although it has been only two months since grid connection, a calculation based on the collected power generation data indicates that HJT Hyper-ion modules have 5.13% higher power generation per watt compared to PERC modules.

Power Generation 5.13% Higher -- Risen Energy Released Empirical Data of HJT Hyper-ion Modules

Retrieved on:

Monday, November 13, 2023

Carbon, Supervision, Topcon, CPVT, LCOE, PERC, Organization, HJT, Carbon footprint, Philosophy, Renewable energy

Risen Energy compared the power generation of HJT Hyper-ion modules relative to PERC modules and TOPCon modules through simulations in over 20 countries and regions around the world with typical climatic environments, as shown in Figure 1.

Key Points:

Risen Energy compared the power generation of HJT Hyper-ion modules relative to PERC modules and TOPCon modules through simulations in over 20 countries and regions around the world with typical climatic environments, as shown in Figure 1.
The simulation results indicate that HJT modules consistently exhibit a significant increase in power generation compared to TOPCon and PERC modules across various regions.
In addition to the simulation, to further explore the real-world power generation performance of HJT Hyper-ion products, Risen Energy collaborated with various organizations and clients to conduct empirical power generation tests in some regions worldwide.
Although it has been only two months since grid connection, a calculation based on the collected power generation data indicates that HJT Hyper-ion modules have 5.13% higher power generation per watt compared to PERC modules.

Solid Biosciences Provides Third Quarter Business Update and Financial Results

Retrieved on:

Wednesday, November 8, 2023

Research, Sale, IND, AAV, Rare disease, Acquisition, Cardiology, Solid, Caregiver, Duchenne, Choroideremia, CMO, Investment, Patient, CPVT, Hypertrophic cardiomyopathy, Pharmaceutical industry, Cryptocurrency, Pfizer

CHARLESTOWN, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today reported financial results for the third quarter ended September 30, 2023, and provided a business update.

Key Points:

“We are pleased with the continued advancement of our diversified pipeline of neuromuscular and cardiac gene therapies; including an IND submission in this quarter for SGT-003 for patients with Duchenne,” said Bo Cumbo, President and CEO of Solid Biosciences.
“We continue to expand our pipeline and last quarter licensed in a gene transfer program to treat catecholaminergic polymorphic ventricular tachycardia (CPVT).
Net loss for the third quarter of 2023 was $21.0 million, compared to $20.4 million for the third quarter of 2022.
Solid had $142.9 million in cash, cash equivalents, and available-for-sale securities as of September 30, 2023, compared to $213.7 million as of December 31, 2022.

Cardurion Pharmaceuticals to Provide Update on CaMKII Inhibitor Program at the American Heart Association’s Scientific Sessions 2023

Retrieved on:

Tuesday, November 7, 2023

Cardurion is the first company to evaluate a CaMKII inhibitor in clinical testing.

Key Points:

Cardurion is the first company to evaluate a CaMKII inhibitor in clinical testing.
The Company will present data on two of its highly selective and potent CaMKII inhibitors, CRD-2015 and CRD-2959, in a preclinical model of heart failure.
Both CaMKII inhibitors prolonged survival in the calsequestrin transgenic heart failure model, which is characterized by a severe dilated cardiomyopathy and early mortality.
The Company next plans to expand this research into more common cardiovascular diseases, such as heart failure and atrial fibrillation.